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A B S T R A C T
Carbohydrates are important as signaling molecules and for cellular recognition events, therefore offer-
ing scope for the development of carbohydrate-mimetic diagnostics and drug candidates. As a consequence,
the construction of carbohydrate-based bioactive compounds and sensors has become an active re-
search area. While the advent of click chemistry has greatly accelerated the progress of medicinal chemistry
and chemical biology, recent literature has seen an extensive use of such approaches to construct func-
tionally diverse carbohydrate derivatives. Here we summarize some of the progress, covering the period
2010 to mid-2015, in CuI-catalyzed azide-alkyne 1,3-dipolar cycloaddition CuAAC “click chemistry” of
carbohydrate derivatives, in the context of potential therapeutic and diagnostic tool development.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
1. Introduction
Carbohydrates play diverse roles in the life cycle of nearly all living
species. Of particular importance are the cell-surface glycan “an-
tennae” that produce multivalent interactions with carbohydrate-
recognition proteins (CRPs). These selective recognition events are
responsible for a wide range of biological events, including the ad-
hesion of white blood cells to sites of infection or tissue damage,
sperm-egg interactions during mammalian fertilization, and the
control of cell fate during differentiation.1–4 However, while
malfunctional glycosylation correlates with fatal human diseases
such as cancer,5 speciﬁc CRPs expressed on the surface of microbial
pathogens can capture normal carbohydrates onhuman cells, leading
to inﬂammation, bacterial adhesion or virus invasion.6,7 As a result,
carbohydrates presentmanyopportunities for intervention indisease
diagnosis and therapy.8 For example, the anti-inﬂuenza agent Tamiﬂu
(oseltamivir) – a sialic acidmimetic that inhibits the activity of neur-
aminidase – acts by preventing completion of the virus life cycle
(see also Fig. 2 and associated text).9 Carbohydrates have also been
employed as probes and sensors to detect carbohydrate–protein
interactions10–12 while eﬃcient solid-phase and solution-based
methods have been developed, promoting the advancement of the
“glycomics” as well as disease diagnosis opportunities.10–12
Despite the elegant carbohydrate chemistries devised by
glycoscientists,13–15 an effective andmodular synthetic approach that
meets the ever increasing interest in the preparation of functional
carbohydrate derivatives is needed. Click chemistry, a synthetic
concept coined by Sharpless et al in 2001, encourages the discov-
ery of simple and modular chemical tools for the effective
construction of diverse compound libraries.16 The advent of the CuI-
catalyzed azide-alkyne 1,3-dipolar cycloaddition reaction (CuAAC),
discovered independently by Sharpless17 and Meldal,18 has revolu-
tionized the way in which chemists consider compound synthesis.
Importantly, CuAAC has eﬃciently ﬁlled the gap between chem-
ists and practitioners beyond the chemical community – including
those who are focused on materials science, biomedicine, nano-
technology, chemical biology and cell biology19,20 – accelerating
discovery and development in contemporary life sciences.
A growing effort has been devoted to the employment of click
chemistry (CuAAC and other click chemistries, such as the thiol-
ene reaction21) for the production of functional carbohydrate
derivatives over the last decade. While several comprehensive
reviews of this topic are available covering the period up to 2010,22–25
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here we summarize some of the impressive progress since that date
in CuAAC-based carbohydrate click chemistry for therapy and
diagnosis.
2. Carbohydrate click chemistry for therapy
2.1. Anticancer activity
Triazolyl carbohydrate derivatives have been synthesized by
CuAAC for evaluation of their anticancer activity, mainly against
cancer cell lines. Carbonic anhydrase (CA) is a transmembrane
enzyme that catalyzes the hydration of carbon dioxide to bicar-
bonate, a process that has proven to facilitate cancer cell survival
in an acidic environment. A number of CA isozymes exist in human
cells, and inhibition of the tumor cell-speciﬁc CAs (such as CA IX)
has been suggested as a strategy for selective cancer therapy.26 In
general, a carbohydrate is used as a hydrophilic tail to bind a hy-
drophilic pocket in CA, with an aryl sulfamides moiety used to target
the catalytic domain (Fig. 1). By CuAAC, both 1,4-disubstituted (1)27
and 1,4,5-trisubstituted (2)28 triazoles with selective, low nanomolar
CA inhibition activities have been synthesized. Co-crystal struc-
tures of the inhibitor-CA complexes revealed the motif by which
the carbohydrate moiety associates with the enzyme.27 Interest-
ingly, dual tail groups (a carbohydrate and an aromatic) were co-
clicked to a CA inhibitor (3), interacting with the distinct hydrophilic
and hydrophobic halves of a CA site.29 Heat shock protein 90 (Hsp90)
is a chaperone for many proteins; the inhibition thereof might be
expected to result in the degradation of multiple proteins related
to cancer progression.30 A series of triazolyl glycocoumarin deriva-
tives were synthesized (4), showing Hsp90-dependent anti-
proliferative activities for breast cancer cells.31
CuAAC was also carried out on the side chain of carbohydrates
to construct enzyme inhibitors with potential anticancer activi-
ties. Protein tyrosine phosphatases (PTPs) dephosphorylate the
phosphotyrosine site of proteins and peptides. The overexpression
and dysfunction of some PTPs are related with cancer.32,33 Consid-
ering the poor pharmacological properties of the highly charged
phosphotyrosine (pTyr), alternative amino acids that might target
the catalytic domain34,35 were used as a surrogate to decorate the
side chain of several glycosides by CuAAC, producing bis-triazolyl
(5)36,37 and mono-triazolyl (6)38,39 PTP inhibitors with micromolar
inhibitory activities. Interestingly, decoration of the amino acids onto
different side-chain positions of carbohydrates yielded distinct PTP
inhibition activities,37–41 suggesting that carbohydrates might serve
as suitable scaffolds to optimize lead compounds. Some such in-
hibitors also showed anti-proliferative activities for selected cancer
cells.38 Salicylate (7),42–44 α-ketoacid45,46 and other pharmacophores47,48
were alternatively used as the pTyr mimetic to modify the C1-,
Fig. 1. Triazolyl carbohydrate derivatives prepared by CuAAC with potential anti-cancer activities.
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C6- or both positions of carbohydrates by CuAAC, and micromolar-
range PTP inhibition activities were obtained. However, further
evidence is needed to conﬁrm that the anticancer properties ob-
served are dependent upon PTP-inhibition.
Other clicked carbohydrate derivatives with cytotoxicity for cancer
cells, but without an identiﬁed molecular target, have been pre-
pared (Fig. 1). Bis-triazolyl amino acids were noted to suppress the
growth of multiple myeloma cells.49 Meanwhile, series of natural
product-carbohydrate triazole conjugates50–52 showed toxicity for
cancer cells, with a glycosyl glycyrrhetinic acid50 selectively induc-
ing apoptosis of a human cervical cancer cell line over a normal cell
line. Glycolipids are an important cell-surface component for
signal transduction. They have been widely used as non-ionic
surfactants due to their amphiphilic nature. Triazole-linked
monosaccharide- (8)53,54 and nucleoside- (9)55 based glycolipid de-
rivatives have been synthesized and identiﬁed to have micromolar
range toxicity for a wide spectrum of cancer cell types. While in-
crease of lipid chain length was found to increase the toxicity, change
of the click conjugation site (anomeric or side chain) and mono-
saccharide (glucoside or galactoside) altered sharply the activity.53,54
Whereas these ﬁndings might provide an insight into the devel-
opment of triazolyl glycolipids as potential anticancer agents, their
mechanism of action needs to be better delineated – is the ob-
served cytotoxicity simply a surfactant effect, for instance?56–58
2.2. Antiviral and antimicrobial activity
Pathogen infections often rely on the interaction of its surface
proteins with the glycocalyx of human host cells. As a result, clicked
carbohydrates that inhibit these processes have been developed as
potential antiviral and antimicrobial compounds. Design and syn-
thesis of pathogen surface glycosidase inhibitors by CuAAC represent
the main strategy.
The neuraminidase (NA) family is an important class of glyco-
sidases that hydrolyze the sialic acid terminus of glycans, modulating
the interaction of host cell with extracellular stimuli. The most well-
known is the surface-expressed NA family of inﬂuenza viruses, which
have caused a series of ﬂu pandemics over many decades. On the
basis of the interaction between sialic acid and NA, zanamavir and
oseltamivir (Fig. 2), two sialic acid glycomimetics, have been de-
veloped to inhibit NA, effectively combating inﬂuenza.8 CuAAC has
been used to dimerize zanamavir, affording 1,4-triazole-linked
zanamavir dimers (10).59 The dimers showed an up to 3000-fold in-
creased inhibitory activity for inﬂuenza A and B viruses with respect
to the monomer. Since multivalent interactions are critical to in-
crease the generally low inherent binding aﬃnity between a single
carbohydrate and a protein, sialic acids have been polymerized.While
a sialylthio-D-galactose fullerene conjugate synthesized by CuAAC
click reaction showed moderate inhibitory activity against NA,60 a
polyglycerol-based nanoparticle functionalized by triazolyl sialic acid
inhibited binding and fusion between an inﬂuenza A virus and a
human erythrocyte quite remarkably.61 The latter study suggested
that both particle size and ligand density are important determi-
nants of antiviral activity, adding insight into the design of
multivalent nanoparticles for interactions at a biological interface.
Clicked sialic acid derivatives have also been developed for other
NAs. Children infected by human parainﬂuenza viruses (hPIVs) may
experience respiratory tract diseases. However, no drugs have been
approved for hPIVs to date. By combining computational and syn-
thetic chemistries with NMR-based structural and biological
techniques, a C4-triazole modiﬁed sialic acid derivative was devel-
oped (11).62 This compound eﬃciently blocked hPIV entry and
progeny virion release by inhibiting the hPIV type 3 hemagglutinin-
neuraminidase (HN), offering a potential preclinical candidate for
combating the virus.
Dysfunction of human neuraminidases (hNEUs) is implicated in
sialic acid storage disorders andmany other diseases. Triazolyl sialic
acid derivatives with a CuAAC modiﬁcation at the anomeric or at
the side chain position have been prepared for inhibition of hNEUs.
A click strategy was used to screen a focused library of aglycone-
modiﬁed sialosides, leading to the identiﬁcation of a hNEU2-
selective, micromolar-range inhibitor (12).63 The CuAACmodiﬁcation
of the anomeric position was found to improve the Ki with minimal
change in the t1/2 of the enzymatic activity. As for the side-chain
click decoration, it was concluded that the C9-, but not the N5Ac-
position, tolerated a triazole-linked hydrophobic group, producing
selective hNEU3 inhibitors (13).64 Similarly, the introduction of a
triazole to the N5Ac position of a sialyl lactoside resulted in the de-
activation of the compound for hNEU3. In contrast, the presence of
a lipid aglycone of the sialyl lactoside was critical for NEU3 binding
(14).65
Iminosugar inhibitors for α-glucosidase, developed by assem-
bling adamantane and iminosugars via CuAAC, were shown to disrupt
viral glycoprotein processing; the increase of linker chain length of
these inhibitors was found to be crucial for their antiviral activity
(15).66 Interestingly, lipid chain length was also found to be crucial
for the anticancer activity of triazolyl glycolipids.53,54 Nonetheless,
the relationship between the micelle-forming ability of these
amphiphiles and their bioactivity needs to be addressed.56–58
Pathogenic bacteria adhesion to host cells often relies on
carbohydrate-protein recognition, as is typiﬁed by Escherichia coli
which can cause urinary tract infections (UTIs). This bacterium uses
the lectin domain of its type 1 ﬁmbriae to bind the terminal
α-mannosyl glycoproteins that are prevalent on epithelial cells of
the urinary tract, leading to tissue colonization. Carbohydrate scaf-
folds that antagonize these recognition events have been developed
(Fig. 3). Employing CuAAC, β-cyclodextrin (CD) was used as a plat-
form to display mannosides in a multivalent manner.67 A heptyl
mannoside grafted β-CD (16) synthesized by a twofold click reac-
tion showed strong type 1 ﬁmbriae (FimH) binding aﬃnity and could
rapidly reach mouse bladder following intravenous injection, with
retention over 24 h preventing E. coli colonization. This study offers
an example for the design of multivalent mannosides with good in
vivo pharmacokinetics. Mannosides have also been introduced to
nanodiamond particle (NDs) surfaces for multivalent display. Mo-
nomeric (17)68 and trimeric (18)69 mannosides were linked to NDs
through triazoles formed by CuAAC, producing “ﬁrst generation” and
“second generation”mannosyl NDs, respectively. These nanoparticles
were found to antagonize type 1 ﬁmbriae-mediated bacterial ad-
hesion to bladder cells, with the “second-generation” being more
potent probably as a result of its increased mannoside valency as
well as an increase of glycosidase stability due to the presence of
S-mannosides. More interestingly, these carbohydrate-grafted
nanomaterials reduced E. coli bioﬁlm formation, an unprecedent-
ed property among all multivalent glycans reported to date.
Inhibition of trans-glycosidase activities using clicked carbohy-
drate derivatives has been developed as a therapeutic strategy for
protozoal infection. Trypanosoma cruzi trans-sialidase (TcTS) is im-
plicated in the pathogenesis of Chagas’ disease – a parasitic blood-
borne parasite infection that occurs widely in Central and South
America.70–74 A triazole-linked sialyl galactose (19) was produced
by CuAAC, and then was identiﬁed to have sub-millimolar inhibi-
tory activity for TcTS and an anti-parasite activity.70 The use of CuAAC
oligomerization of azido-alkyne functionalized galactose building
blocks was shown to give rise to macrocycles and linear oligom-
ers, the former capable of serving as TcTS substrates and of blocking
macrophage invasion by T. cruzi (20).71,72
Tuberculosis, caused by Mycobacterium tuberculosis, is a leading
cause of mortality in many countries. Its carbohydrate-based cell
wall plays a major role in drug resistance – blocking drug uptake
– and persistence of the organism in infected macrophages. A
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number of potential glycobiology drug targets for tuberculosis
therapy are therefore evident.
Click chemistry has been used to produce 1,6-oligmannosides,
of which the hexa-mannoside and octa-mannoside (21) showed the
highest activity against mycobacterial α-1,6-mannosyltransferases.75
This suggests that the length of the linear oligomerization impacts
the activity of the resulting oligo-mannosides. Alternatively, a focused
small molecule library was prepared by CuAAC for M. tuberculosis,
among which a per-acetylated glycosyl quinoline hybrids showed
better activity than a carbohydrate-free control compound.76
In addition to the discussed triazolyl carbohydrates with anti-
microbial activities, click derivatization was carried out on
Fig. 2. Triazolyl carbohydrate derivatives prepared by CuAAC with potential antiviral activities.
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conventional antibiotics scaffolds, such as amino sugars,77,78
macrolides and aminoglycosides.79 While a clicked tobramycin-
based cationic amphiphile (22) suppressed the growth of both gram-
positive and gram-negative bacterial strains,80 the presence of a
triazolyl glycolipid derivative (23) enhanced the drug susceptibil-
ity of a superbug, MRSA (Staphylococcus aureus).81 Interestingly, the
combined use of 23 lowered the MIC (minimal inhibitory concen-
tration) of a range of commercial β-lactam antibiotics, upward of
256-fold, for both ATCC and clinical MRSA isolates. Preliminarymech-
anistic investigations showed that the combination lowered the
expression of a protein (penicillin binding protein 2a) that resists
β-lactam drugs. In addition, the fact that a triazole-free glycolipid
analogue did not show a similar synergistic effect highlighted the
importance of the triazolyl moiety for the activity. This research pro-
vides a new glycolipid weapon for disarming superbugs.
Collectively, while multivalent display of carbohydrates that are
recognized by bacterial glycosidases is an effective tactic to antag-
onize bacterial adhesion, click glycosylation of conventional
antibiotics might be a promising strategy to enhance the pharma-
cological properties of the resulting glycosyl derivatives.
Fig. 3. Triazolyl carbohydrate derivatives prepared by CuAAC with potential antimicrobial activities.
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2.3. Other glycosidase and glycosyltransferase inhibitors
In addition to their involvement in infectious processes, many
glycosidases and glycosyltransferases are implicated in other patho-
logical events (Fig. 4). Gaucher’s disease (GD) is a lysosomal storage
disorder caused by mutations in, and therefore deﬁcient activity of,
glucocerebrosidase (GCase), which hydrolyzes glucosylceramide.
Iminosugars are carbohydratemimetics where the endocyclic oxygen
is replaced by a nitrogen atom. CuAAC was carried out to connect
iminosugars with adamantane; the resulting conjugates (24) showed
sub-micromolar inhibitory activity against GCase, being at least 10-
fold more active than unmodiﬁed iminosugars.82,83
As glycomimetics of iminosugars, aminocyclitols were conju-
gatedwith lipids of different chain length by CuAAC, producing GCase
inhibitors with nanomolar inhibitory activity (25).84,85 A computa-
tional docking study suggested the crucial role of triazole for enzyme
inhibition and thermal stabilization. Meanwhile, click chemistry
proved applicable for preparing triazolyl carbohydrate libraries as
broad range glycosidase and glycosyltransferase inhibitors. Build-
ing on earlier work,86 both aglycone- and sidechain-modiﬁed
carbohydrate triazoles were synthesized by CuAAC, showing ac-
tivities for glucosidases87–91 and mannosidases (26, 27, Fig. 4).92,93
In contrast to glycosidases, glycosyltransferases catalyze the for-
mation of glycosidic bonds. During these processes, a nucleotide
diphosphate sugar (NDP) is typically used as the substrate, with
transfer of a carbohydrate to an acceptor substrate. As a result, phos-
phate or pyrophosphate mimetics are frequently involved in
glycosyltransferase inhibitor design, in order to decrease polarity.
Therefore, neutral carbohydrate inhibitors have been developed by
CuAAC. Pyridine was used as a pyrophosphate surrogate to click with
carbohydrates, producing galactosyltransferase inhibitor (28)94 and
N-acetylglucosaminyltransferase (OGT) inhibitor (29).95 However,
both crystallographic and docking analyses suggested that the car-
bohydrate head groups do not occupy the catalytic site, with little
interaction with the enzymes. These triazoles probably have the po-
tential to be developed as carbohydrate-based metal chelators for
sensors design (see later section). Triazole-linked glycosyl
naphthalimide was prepared for OGT inhibition, and the aglycone
was proposed to generate π-stacking with a tryptophan residue of
the enzyme.96 Series of sialyltransferase inhibitors, exempliﬁed by
compound (30), with different molecular shapes and properties were
also synthesized by CuAAC.97 It was determined that the charge and
hydrophobicity of these compounds contributed predominantly to
their inhibitory activity.
In an anti-bacterial discovery program, lactose was clicked to a
microplate, followed by poly-sialylation with poly-sialyltransferase
from Neisseria meningitidis. This platform has proven suitable for
screening inhibitors of this glycosyltransferase.98 To prevent infec-
tion by human pathogenHelicobacter pylori (H. pylori), triazole linked
GDP-fucose conjugates were synthesized, some of which showed
inhibitory activity for H. pylori α1,3-fucosyltransferase.99 Interest-
ingly, triazole-linked mannosyl oligomers prepared by CuAAC were
used as an acceptor for a mycobacterial mannosyltransferase, es-
tablishing a useful small molecule assay for the enzymatic activity.100
Glycogen phosphorylase (GP), which catalyzes the phosphoroly-
sis of glycogen, is a validated therapeutic target for type 2 diabetes
mellitus. To the C1-position of the glucose scaffold that docks into
the catalytic site, a variety of aromatic aglycones were introduced,
by CuAAC, to target a hydrophobic site of GP (31 as a representa-
tive example).101–104 However, these triazolyl inhibitors showed
moderate activities, suggesting that a more elaborate selection of
hydrophobic aglycone as well as the use of glycomimetics, beyond
glucose, might be needed to associate with the catalytic site of GP
with a higher aﬃnity.
Fig. 4. Triazolyl carbohydrate derivatives prepared by CuAAC for glycosidases and glycosyltransferases.
6 X.-P. He et al. / Carbohydrate Research 429 (2016) 1–22
2.4. Immunostimulating activity
The fact that carbohydrates play a pivotal role in the mammalian
immune system has spurred extensive efforts in constructing
carbohydrate-based immunostimulating agents.105 Natural killer T (NKT)
cells express both a T cell receptor (TCR) and natural killer cell recep-
tors. They recognize glycolipid antigen/CD1dcomplexby theTCR, rapidly
releasing cytokines, such as interleukins (ILs) and interferon-γ (IFN-γ).
The released cytokines eventually lead to activation of innate and adap-
tive immune responses.106,107 Theﬁrst andmostwell-studiedTCRagonist
is an α-galactosyl ceramide (α-GalCer or KRN7000) (Fig. 5).108 On the
basis of this scaffold, triazolyl derivatives synthesized by CuAAC have
been developed. The click strategy can be divided into the following
three aspects: 1) Cer (ceramide)-modiﬁcation, 2) Gal (galactose)-
modiﬁcation and 3) oligomerization (Fig. 5).
The amide linkage of Cer has been replaced by a bioisosteric
triazole, coupling a set of alkyl chains of different length.109 The re-
placement was determined to upregulate the release of both IL-4
and IFN-γ from an NKT cell line, with long-chain triazole ana-
logues (32) being more potent than their short-chain counterparts.
A docking study suggested that the triazole moiety might form hy-
drogen bonds with amino acid residues of CD1d, thereby inﬂuencing
the cytokine release proﬁle. A preliminary in vivo test suggested that
the triazolyl α-GalCer derivatives induced greater IL-4 secretion into
the serum of a mouse model than a control.109 This pioneering study
established a basis for the development of α-GalCer derivatives by
the CuAAC click chemistry.
In addition to the lipid chain and anomeric carbon of
α-GalCer,109–111 the Gal residue itself has also been modiﬁed by click
chemistry. Coupling of aliphatics, but not aromatics, to the C6-
position of Gal, as in (33), by CuAAC produced triazolyl α-GalCer
derivatives with increased ability to release cytokines both in vitro
and in vivo compared to α-GalCer.112,113 Considering that CD1d mol-
ecules show localized clustering properties, a click dimerization was
carried out to crosslink the C6-positions of two independent
α-GalCers, producing a homo-dimeric α-GalCer (34),114 Although
no obvious improvement in immunostimulating effect was ob-
served for the dimers (which precluded a plausible bivalent effect),
this study encourages the multivalent display of α-GalCer for high
avidity binding with clustered CD1d. A similar strategy was devel-
oped to form awater-soluble β-GalCer-containing dendritic polymer
by CuAAC for enhancing the interaction with HIV-1 gp120 (35).115
Finally, analysis of the crystal structure of a TCR-α-GalCer-CD1d
ternary complex identiﬁed that the α-methylene unit of the fatty acid
moiety could be amenable to introducing a label for biochemical
studies. Biotinylated and ﬂuorophore-labeled α-GalCer (36) were thus
synthesized, both showing a comparable activity to unlabeled
α-GalCer. This study offers a useful labeling approach for tracking the
in vivo behavior of CD1d agonists.116 Since the stability of the TCR-
α-GalCer-CD1d ternary complex is crucial for the immunostimulating
effect, development of α-GalCer (the cross-linker between TCR and
CD1d) derivatives has become the main strategy for more tightly as-
sociating the two proteins. In this sense, click chemistry has
successfully made possible the ﬂexible functionalization of α-GalCer
at both the Gal (TCR binder) and the Cer (CD1d binder) ends.
The development of carbohydrate-based vaccines has become
a popular topic in recent years because of the existence of speciﬁc
carbohydrate antigens on tumor cells. However, the major issue
related to this subject is the low immunogenicity of the endog-
enous carbohydrate antigens. Click chemistry has been used to
conjugate the poorly active carbohydrate antigens with a vaccine
adjuvant, or to display the antigens in a multivalent manner.117–121
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Fig. 5. Triazolyl carbohydrate derivatives prepared by CuAAC as α-galactosyl ceramide (α-GalCer) mimetics.
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The most researched examples have been the Tn and sialyl-Tn (STn)
tumor-associated antigens (Fig. 6).
On the basis of the sophisticated syntheses of triazolyl glyco-
peptide, glycoprotein and glycolipid derivatives by CuAAC,117,122–124
Tn or STn peptide was coupled to a lipopeptide through click chem-
istry. It was determined that the vaccine with four copies of antigen
(37) showed a remarkable cluster effect, without the need for use
of external adjuvant, inducing antibodies that suppress the viabil-
ity of MCF-7 breast tumor cells.118 Interestingly, the Tn antigen has
also been attached to bacteriophage Qβ virus-like particles (38),119
eliciting much higher levels of antibodies than other virus-like par-
ticles. The antibodies produced strongly reacted with native Tn
antigens on human leukemia cells, proving the effectiveness of dense
multivalent display of carbohydrate antigens on a particle surface
for vaccine design. In an alternative approach, a safe and potent
immunostimulant, monophosphoryl lipid A, was used as a built-
in adjuvant for click conjugation with a tumor-associated
carbohydrate antigen, GM3 (39).120,121 The vaccine elicited robust
antibody responses, and the antibodies produced bound selec-
tively to target tumor cells. As a combined strategy, the multivalent
display of carbohydrate antigens with a built-in immunostimulant
by click chemistry can be anticipated.
2.5. Multivalent and small molecule carbohydrates for high-aﬃnity
lectin association
Carbohydrates often require multivalent display to associate
strongly with their cognate, oligomeric binding proteins due to the
typically poor aﬃnity of monovalent carbohydrate–lectin associa-
tions. On the one hand, click chemistry has proven a modular tool
to couple carbohydrates to a variety of multivalent backbones due
to its regio- and stereo-speciﬁcity and functional group tolerance.
On the other hand, small-molecule carbohydrates with enhanced
binding aﬃnity with a lectin pair have been discovered from click-
based high-throughput libraries. A comprehensive review with
respect to this speciﬁc subject has been published recently.125
The frequently selected backbones on which carbohydrates are
presented in multivalent format include dendritic scaffolds, pep-
tides, polymers as well as carbohydrates. Dendrimers have emerged
as a promising material for imaging and drug delivery applica-
tions because of their structural homogeneity, controllable
degradation and the ability to entrap bioactive compounds. Den-
dritic presentation of carbohydrates has proven effective to increase
remarkably the binding avidity of the resulting glycodendrimers for
lectins. The relative potency (r.p.) was used to measure the en-
hancement of lectin binding aﬃnity of a multivalent glycol-
scaffold comparing to a monovalent carbohydrate (Fig. 7).
Both low valency and high valency glycodendrimers have been
prepared by CuAAC.126–131 For example, trivalent presentation of a
LeX trisaccharide (Lewis X determinant) by CuAAC on a carbosilane
core yielded an r.p. of 92 for lotus lectin compared to the monomer
(40).126 An “onion peel strategy” was developed by combining
the thiol-ene and the CuAAC click chemistry to display
N-acetylactosamine (LacNAc) at each layer of a dendritic growth.
A glycodendrimer with 29 triazolyl LacNAc copies showed a re-
markable r.p. of 1168 for a LacNAc-speciﬁc leguminous lectin.128 By
Fig. 6. Triazolyl carbohydrate derivatives prepared by CuAAC as vaccines.
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Fig. 7. Multivalent triazolyl carbohydrate derivatives prepared by CuAAC based on various scaffolds.
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combining glycomimetic and multivalent strategies, a C-galactoside
was clicked to a dendritic backbone, showing a 409 r.p. for PA-IL
lectin (41).129 Moreover, a strain-promoted azide-alkyne cycload-
dition (SPAAC) was used to assembly two independent dendrons,
leading to a heterobifunctional dendrimer (42).130
Glycoclusters based on structurally deﬁned, rigid cores such have
also been constructed by CuAAC.131–139 Lactose-appended
calix[4]arene glycoclusters showed a 625 r.p. for galectin-1 com-
pared to a monovalent counterpart.135 Ganglioside GM1 derivative
(43), produced by CuAAC with a calix[5]arene, exhibited a remark-
able 100,000 r.p. for cholera toxin compared to a control monomer.136
Chromogenic core scaffolds, such as porphyrin137,138 and perylene
bisimide139 dyes, have also been employed to display carbohy-
drates, imparting the resulting glycodendrimers with an inherent
optical signal for biological assays. Interestingly, in two systemat-
ic studies, glycoclusters with different linker arms (with varied
rigidity and hydrophilicity) coupling carbohydrate epitopes to the
above scaffolds were prepared by CuAAC.137,138 It was concluded that
the geometry and topology of the core scaffold and linker rigidity
had a large impact on the binding of the glycoclusters to lectins.
Overall, these studies highlight the power of click chemistry in the
concise construction of diverse and complex carbohydrate struc-
tures for elaboration of structure-lectin binding activity relationships.
Click chemistry-based glycol-polymerization has been carried
out as another strategy to obtain multivalent carbohydrate
presentation.140–142 (Readers are directed to a recent review on the
construction of glycopolymers.143) Besides the conventional chain
transfer polymerization followed by CuAAC approach to clustered
carbohydrates,143 peptides have been used extensively as the back-
bone to produce polymeric carbohydrate-containing architectures,
since glycopeptides/proteins and proteoglycans are prevalent glyco-
structures in nature. CuAAC has been shown to be effective for linking
carbohydrates to various functional peptide and protein back-
bones with a deﬁned secondary structure.144–151 These glycopeptides
showed enhanced cellular uptake145 and potential for use in tissue
engineering (44).146 Given the importance of peptide conforma-
tion towards its biological functions, glycopeptidomimetics with
unnatural peptide bonds have been developed by click chemistry
(45).148,149 It was found that subtle conformational change of the gly-
copeptidemimetics impacted largely their associationwith lectins.148
Toward a similar end, carbohydrates themselves have been used as
the core scaffold for multivalent carbohydrate display (Fig. 8).
Through CuAAC conjugation of multiple mannoside copies to
mannoside cores, triazole-connected high-mannose glycanmimetics
have been developed (46).152 Beyond a simple multivalent presen-
tation, X-ray crystallography analysis suggested that these
compounds are real “structural mimetics” of the high-mannose oli-
gosaccharides. In addition to CuAAC, ruthenium catalysis was found
effective toward the synthesis of a thiolactoside based glycocluster.153
Carbohydrates have also been clicked to cyclic and linear
polyglycosyl scaffolds. Both cyclic glucosamines (47)154 and
cyclodextrins (CDs) (48)155 were determined to be suitable centers
to improve lectin binding, with the latter addressing high loading
capacity of hydrophobic anti-cancer and anti-HIV drugs. A Lactose-
clicked inulin (β-2,1-fructan)glycopolymerwas synthesizedbyCuAAC,
and the inulin sidechain-modiﬁed click adduct lowered the critical
gelation concentration with respect to that of natural inulin.156 In
contrast, triazole-linked carbohydrate repeating units prepared by
CuAAC were used to space galactoside units; compared to a con-
ventional ﬂexible linkage, the rigidity of the triazolyl carbohydrate
spacer was determined to greatly facilitate a lectin binding, with
an r.p. of up to 7555 for (49).157,158 This observation allows for the
developmentofmultivalent glycoscaffoldswithapre-organized struc-
ture using the biocompatible and rigid carbohydrates as the spacer.
Contrary to the multivalent strategy, identiﬁcation of small mol-
ecule glycomimetics from click libraries has also proven suitable for
drastically improving lectin binding aﬃnity (Fig. 9). The siglec family
comprises a number of sialic acid-binding proteins expressed on
cells of the mammalian immune system.159 Sialic acid derivatives
that target these lectins might thereby facilitate cell type-speciﬁc
therapies. Thanks to the modularity and effectiveness of CuAAC click
chemistry, series of sialoside libraries have been prepared in a high-
throughput manner. The resulting crude mixtures were further
immobilized onto a solid phase and screened for their ability to bind
siglecs. On the basis of this straightforward approach, triazolyl
sialosides with excellent selectivity for homologous siglecs have been
identiﬁed.160–162 Interestingly, click decoration of different substitu-
ents on the same position of sialic acid led to distinct speciﬁcity of
the resulting triazoles for different siglecmembers, including siglec-7
(50),161 siglec-9 (51),160 siglec-10 (52)160 and human CD22 and CD33
associated with myeloid leukemia and B cell lymphoma.162 Other
sialoside mimetics have similarly been prepared by click chemis-
try. In particular, a sialyl LewisX mimetic (53) showed nanomolar
E-selectin antagonistic aﬃnity with a signiﬁcantly prolonged t1/2 with
respect to its natural counterpart.163
Galectins are implicated in the progression of cancer, inﬂam-
mation and heart disease.6 Both lactoside and galacto-coumarin
derivatives have been prepared by CuAAC for galectin binding at both
the molecular and cellular levels.163–166 However, aglycone modiﬁ-
cation was noted to also convey cytotoxicity.164 Clicked galactosides
have been further developed for cholera toxin inhibition167,168 and
for targeting a galactose-selective C-type lectin, the asialoglycoprotein
receptor (ASGPr).169 The ASGPr is highly expressed on hepato-
cytes, modulating the clearance of serum asialoglycoproteins. High
aﬃnity agents that target this receptor may facilitate liver-speciﬁc
drug delivery. A C6-triazole-modiﬁed galactomimetic (54)169 showed
a 55-fold better binding aﬃnity for the ASGPr than the parent car-
bohydrate, offering a useful warhead molecule for drug delivering
systems.
While the multivalent glycoscaffolds constructed by click chem-
istry might provide insight into the construction of functional
macromolecules for biomedical applications, the success in high-
throughput screening of bioactive small-molecule carbohydrate
derivatives by CuAAC encourages the use of carbohydrates as start-
ing materials to optimize bioactive compounds.160–170 The latter
strategy has not been limited to screening lectin antagonists, as high-
lighted by a recent study on the development of a heparan sulfate
click library for binding ﬁbroblast growth factors (55), for instance.171
3. Carbohydrate click chemistry and diagnostics
Given their ability to selectively interact with cell surface re-
ceptors, carbohydrates have been used as a warhead to construct
glycoprobes for the detection of pathogenic targets. In general, these
probes are composed of a carbohydrate as recognition/targeting
group, a signaling tag as a reporter and, in some cases, a third com-
ponent as a receptor for speciﬁc intracellular species such as ions,
small molecules and biomacromolecules. The most extensively re-
searched constructs have been the ﬂuorescence glycoprobes because
of the sensitivity and ease of manipulation of ﬂuorescence sensors
(here readers are directed to a themed issue guest edited by Chang,
Gunnlaugsson and James).172 Click-conjugated glyco-nanoparticles
and electrochemically-active glycoprobes have also been devel-
oped. Thanks to the modularity of CuAAC click chemistry, these
diagnostic systems could be constructed in a facile manner.
3.1. Clicked ﬂuorescence glycoprobes and ﬂuorogenic composite
materials for lectin detection and live cell imaging
Recently, series of carbohydrate-ﬂuorescent dye conjugates
(glycodyes) have been synthesized by CuAAC click chemistry (Fig. 10)
for the detection of lectins and carbohydrate receptors on the surface
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of live cells. A rhodamine-GalNAc adduct (56) was prepared for tar-
geting the ASGPr that exists on both hepatocytes and hepatoma
cells.149,173 Although the physiological function of ASGPr is to clear
excess or aging galactose-terminated proteins in circulating blood,
the receptor has also been identiﬁed as an invasion site for hepatic
viruses; the ASGPr is overexpressed during liver inﬂammation.174
As a consequence, high-aﬃnity probes that antagonize ASGPr-
ligand interactions might be useful tools for disease theranostics
(i.e. combined diagnostic and therapeutic).149,173,174 Using 56 as a ﬂu-
orescence probe,149 the antagonist effect of a glycopeptidomimetic
(45) for GalNAc-ASGPr interactions was determined, providing a
unique tool for the analysis of receptor-glycoligand recognition di-
rectly at the cellular level.149
On the basis of the aﬃnity of 56 for transmembrane ASGPr, a
ﬂuorogenic composite material (FCM)173 was constructed using
graphene oxide (GO) as a base substrate for ligand presentation. GO,
owing to its broad adsorption band, water solubility and large surface
area, has been widely used as a quenching material (by mainly the
Förster resonance energy transfer [FRET] mechanism) for optical
biosensors.174–179 56 was used to self-assemble with GO, presum-
ably by π-stacking and electrostatic contacts, forming a GalNAc-
coated FCM with quenched ﬂuorescence.173 The resulting material
Fig. 8. Multivalent triazolyl carbohydrate derivatives prepared by CuAAC based on carbohydrate scaffolds.
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was shown to be suitable for the imaging of liver cancer cells
overexpressing ASGPr (Fig. 11), whereas change of the carbohy-
drate warhead to GlcNAc or knock-down of the receptor led to a
clearly decreased signal. As such, this study establishes a new
glycomaterial platform for probing cancer cells. More interest-
ingly, because of the large surface area of GO, the glycodyes are
presented in a multivalent manner, suggesting an alternative, non-
covalent self-assembly strategy for acquiring carbohydrate
multivalency, in contrast to covalent approaches.125,143
Considering that multiple carbohydrate receptors may co-exist
on a single cell, a duplexed FCM was constructed for the simulta-
neous detection of two lectin receptors.180,181 A Gal-DCM
(dicyanomethylene, 57) and aMan-coumarin (58) were co-assembled
on a single GO surface, quenching the ﬂuorescence of both. It was
observed that the presence of a single lectin receptor recovered the
ﬂuorescence of the cognate glycodye, whereas the dual emission
could be observed simultaneously when both lectin receptors were
present. This research offers a versatile tool for the simultaneous
detection of multiple disease biomarkers. It was also determined
that the size of GO had a large impact on both the lectin sensing182
and cellular imaging183 effect of ﬂuorophore-labeled carbohy-
drates. Using GO with an optimal size, a supramolecular system
where a glycoprobe and an anticancer drug were co-assembled to
a single GO surface has been developed for receptor-targeting
theranostics.183
A tetrameric Man-FBT (benzothiadiazole, 59) was constructed
to assemble with GO for detection of a Man-selective lectin as well
as a Gram-negative bacterium (E. coli) that expresses a cell surface
mannose receptor (see also earlier section).184 Porphyrin was also
shown to be a suitable scaffold to click with Gal, producing a
glycodye, (60), to be installed in a ﬁeld-effect transistor device.185
It was found that, comparing to GO, the use of carbon nanotubes
enhanced the sensitivity of the device, probably because of a mor-
phological effect. These studies highlighted the versatility of
glycodyes for the construction of carbon material-based diagnos-
tic tools, with the dye molecules as the essential material binder
to non-covalently present the carbohydrate ligands. In addition to
the non-covalent assembling strategies, we note that covalent cou-
pling of carbohydrates with GO has also been prepared by CuAAC.186
Other supramolecular strategies have also been developed, in-
cluding the self-assembly between a clicked triazolyl pyrenyl CD (61)
and 56 was carried out for the ﬂuorogenic detection of lectins.187
Spectroscopic analyses suggested that the structure of the CD is
tubular, thus facilitating the stacking of the rhodamine moiety of
56 to the pyrene cluster. The ﬂuorescence of 56was quenched upon
supramolecular assembly, probably due to a static quenching mech-
anism (that 56 and 61 form a ground-state complex before
excitation). Subsequently, the presence of a lectin selective for the
sugar ligand recovered the ﬂuorescence, suggesting the competi-
tive dissociation of the complex formed between 56 and 61 (Fig. 12).
Fig. 9. Triazolyl glycomimetics prepared by CuAAC for lectin binding (the dashed lines of compounds 50–52 mean that they are bound to a surface).
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This research provides an all-carbohydrate-based, supramolecular
sensing system for the homogenous detection of lectins.
Aggregation-induced-emission (AIE), which is contrary to
the conventional aggregation-induced quenching, is a unique
photophysical phenomenon where the emission of certain weakly
ﬂuorescent dyes intensiﬁes upon aggregation.188–192 A red-emitting
diketopyrrolopyrrole (DPP), which is a typical AIE dye, was used to
couple with carbohydrates through CuAAC, producing a glycodye
with a weak emission (62).193 It was observed that supramolecu-
lar self-assembly of 62 with a selective lectin produced strong red
emission arising from AIE, setting a basis for the development of
AIE-based lectin probes (Fig. 13).
Other small molecule glycodyes based on pyrene,194 porphyrin195
and boron-dipyrromethene (BODIPY)196–198 with the ability to sense
biomolecules or to image live cells, and glyco-photochromic
compounds,199 have similarly been developed by CuAAC chemistry.
Fig. 10. Triazolyl glycodyes for the probing of lectins and/or live cells.
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Fig. 11. Supramolecular self-assembly between glycodyes and graphene oxide (GO)
as substrate for the ﬂuorogenic detection of lectin receptors.
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3.2. Clicked ﬂuorescence glycoprobes for ions and small molecules
In addition to probing lectin receptors, carbohydrate based small-
molecule glycodyes grafted with an additional receptor site for an
ionic analyte have also been developed (Fig. 14). In these glycodye
ion probes, the triazole ring serves as a linker and, sometimes a che-
lator for a metal ion because of its ability to coordinate with
cations.200–205
Despite the physiological role of the copper (II) ions (Cu2+), their
accumulation in the human body may cause disease.206 A bis-
triazolyl per-acetyl glucosyl anthraquinone was synthesized by
CuAAC (63). The strong coordination of the bis-triazolyl motif with
Cu2+ induced the ﬂuorescence quenching of the glycodye, possibly
due to an intramolecular charge transfer (ICT) process.207 Mean-
while, because of the electrochemical activity of quinone, a
voltammetric method was also used for Cu2+ detection. Some ﬂu-
orescence “off–on”-type glycodyes have also been developed, since
quenching-based probes are not ideal for cellular imaging pur-
poses due to the high background signal. Rhodamine-based small
molecule ﬂuorescence probes have been extensively reported in the
literature due to their sensitive lactam-ring opening property upon
recognition of an analyte, producing both a strong ﬂuorescence and
a colorimetric change.208,209 On the basis of this simple rationale,
series of rhodamine-based glycodyes were prepared by CuAAC.
Mercury ion (Hg2+) is highly neurotoxic to mammals; the
glycorhodamine probes (64–66) developed were principally selec-
tive for Hg2+.210–212 A per-acetyl galactosidewas used as an FRET donor
to conjugate with rhodamine as an FRET acceptor because of the
overlap of the emission band of the former with the absorbance band
of the latter (64). Upon chelation with Hg2+, FRET occurred between
the two ﬂuorophores, leading to quenching of the acetyl galacto-
side but ﬂuorescence emission of rhodamine.210 On the basis of the
above study, a bis-triazolyl galactosyl rhodamine (66) was
developed,212 in which the galactose served as a targeting agent for
ASGPr of a liver cancer cell. It was determined that, among a series
of cancer cells pre-incubated with Hg2+, only a hepatoma cell with
ASGPr expression showed selective probe endocytosis, and thus ﬂu-
orescence emission due to chelation of the probe with intracellular
Supramolecular
assembly
Fluorophore
Glycoligand
61
=
Lectin receptor
competition
56
Fig. 12. Supramolecular self-assembly between a glycodye and pyrenyl cyclodextrin (CD) for the ﬂuorogenic detection of lectin receptors.
=
62 (Gal-DPP)
Supramolecular
assembly with 
lectin receptor
Weak 
emission
AIE!
Fig. 13. Supramolecular self-assembly between a glycodye and a lectin receptor for aggregation-induced-emission (AIE).
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Hg2+. While knockdown of the receptor led to suppression of the
ﬂuorescence signal, the change of the galactoside to a non-
carbohydrate poly(ethylene glycerol) (PEG) chain led to unselective
ﬂuorescence generation in all cells tested.213 This suggests that
glycosylation of small molecule probes could substantially enhance
their targeting ability for cells with a cognate carbohydrate recep-
tor. Similar observations have been reported using the “click
glycosylation” strategy to modify known zinc ion (67)214 and H2S
(68)215 probes, leading to their enhanced hepatocellular selectivi-
ty. These studies demonstrate the generality of the click glycosylation
strategy, in combination with the effectiveness of CuAAC, setting a
simple basis for the target-speciﬁc imaging of intracellular species.
Alternatively, the addition of a carbohydrate warhead to a thiophenol
(Tp) probe (69) improved its water solubility for the transient de-
termination of Tp in environmental water samples.216 The use of
carbohydrate targeting strategy has also facilitated the selective de-
tection of intracellular pH217 and enzymatic activities.218
3.3. Clicked ﬂuorescence glycoligands
Considering their precisely oriented hydroxyl groups, carbohy-
drates have also been employed as a scaffold on which to install
diverse ﬂuorophores by CuAAC click chemistry, producing so-
called glycoligands (Fig. 15).219 Furanosyl carbohydrate scaffolds were
ﬁrst used to conjugate with pyridine (70)220 and benzothiadiazole
(71)221 by a twofold click reaction, producing conformationally-
constrained glycoligands for Cu2+. A ligand was proven to passively
cross membranes of living cells by ﬂuorescence imaging.222 In-
formed by these studies, pyranosyl carbohydrate scaffolds modiﬁed
by CuAAC were also employed to display a diverse range of
Fig. 14. Triazolyl glycodyes with an additional ionic receptor site.
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ﬂuorophores. Bis-triazolyl coumarin glycoligands developed showed
a selective ﬂuorescence response to the toxic silver ions (Ag+).223–225
Notably, it was determined that the introduction of the bis-
triazolyl to different positions of an identical glucopyranosyl scaffold
could lead to the production of completely reverse ﬂuorescence
signals upon chelation with Ag+. Whereas the C3,4-disubstituted
glycoligand (72) showed a quenched ﬂuorescence upon chelation
with Ag+,223 the C2,3-disubstituted counterpart (73) exhibited a re-
markably enhanced ﬂuorescence in the presence of the ion.225 The
latter observation was tentatively ascribed to a chelation-enhanced
ﬂuorescence mechanism, suggesting the versatility of using the car-
bohydrate scaffold for sensor design.
The introduction of two different ﬂuorophore molecules to the
same carbohydrate pyranosyl scaffold was found to render diver-
sity in metal ion selectivity.46,226,227 By modifying the adjacent
hydroxyl groups of the side chain of glycosyl scaffolds, ﬂuorophore
excimers (excited dimer) could be formed.227 The eximer ﬂuores-
cence was used to detect heavy metals in a selective manner.
Macrocyclic carbohydrate based glycoligands were also developed
through intramolecular CuAAC reactions,228,229 producing interest-
ing cyclic glycoligands for guesting metal ions (75).230
Instead of using organic ﬂuorescence dyes as the signal report-
er, nanoparticle materials have also been functionalized by clicked
carbohydrates for the colorimetric detection of lectins.231–236
Polydiacetylene (PDA) was clicked with mannosides and lactosides,
and the resulting glyco-PDAs were converted to liposomes by
photopolymerization. The nanoparticles formed showed a subtle
colorimetric transition upon binding with selective lectins with
an ene-yne polymeric reporter responsible for the chromatic
transitions.231 Interestingly, considering their sensitive colorimet-
ric change upon aggregation, gold nanoparticles (AuNPs) were also
coated with carbohydrates (Fig. 16).233–236 Seasonal inﬂuenza causes
a number of human deaths each year, and the pandemic as a result
of the inﬂuenza virus crossing from animal species is of particular
concern. The hemagglutinin on the inﬂuenza virus particle surface
can recognize a sialic acid-terminated trisaccharide on host cells,
thereby leading to virus invasion. A trimeric glycomimetic (76) of
the trisaccharide coupled with an alkanethiol chain by CuAAC was
coated to AuNP, and the resulting glyco-AuNPs showed a rapid colo-
rimetric change with non-puriﬁed inﬂuenza virus in allantoic ﬂuid
as a result of virus particle-induced aggregation. Importantly, the
probe was also able to discriminate human and avian strains of
Fig. 15. Triazolyl glycoligands prepared by the CuAAC click chemistry.
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Fig. 16. Carbohydrate derivatives prepared by click chemistry for the functionalization with glyco-nanoparticles (AuNPs).
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inﬂuenza virus.235 A recent study also suggested the possibility of
using facile strain-promoted click chemistry (77) for the self-
assembly of core-shell glyco-AuNPs for speciﬁc detection of
galactose-binding lectins.236
3.4. Click chemistry for electrochemically active glycoprobes
Electrochemistry is a sensitive technique that has been widely
applied for the construction of biosensors.237–243 To complement
several other surface/interface-based techniques by click
chemistry,244–250 electrochemically active carbohydrates have been
synthesized and assembled to different electrode materials for de-
tection of lectin and live cells (Figs. 17 and 18). While previous
studies mainly made use of the classic alkanethiol-gold electrode
self-assembly for the fabrication of electroactive carbohydrate
monolayers,251 new approaches using other electrodematerials have
been developed. GO, because of its goodmolecular adsorption ability
and unique electric properties, has been established as an effec-
tive alternative.252–254
An anthraquinone (AQ)-labeled galactoside (78) was synthe-
sized by CuAAC. The AQ redox center served not only as an
electrochemical reporter but also a binder to graphene surfaces
through π-stacking.255 It was determined that 78 could self-
assemble to the surface of the graphene working electrode area of
a screen-printed electrode,256,257 producing an electrical signal.
However, replacement of the graphene electrode by graphite re-
sulted in a much weakened signal, suggesting the importance of
graphene for signal ampliﬁcation. The system constructed was suc-
cessfully used for the voltammetric detection of lectins as well as
liver cancer cells highly expressing ASGPr; RNAi knockdown of the
receptor led to suppressed voltammetric response.255
Subsequent investigations using a longer PEG linker connect-
ing the AQ and glycoside, (79), suggested the suitability of clicked
glyco-AQs, in combination with graphene, for the impedance de-
tection of lectins.258,259 To reinforce the association between the AQ-
labeled carbohydrates with graphene, an additional pyrene group
was introduced to the electroactive probe (80). Based on the strong
π-stacking of pyrene with graphene, the resulting graphene com-
posite electrode enabled the dynamic tracking of the expression level
of pathogenic receptors expressed on different live cells.260 Notably,
the above studies only required a portable and miniaturized elec-
trochemical workstation in connection with a personal laptop,
making possible a simple new technique for the economic point-
of-care disease diagnosis. In addition to AQ as the electroactive
species, ferrocene was used to couple with propargyl mannoside
by CuAAC. The resulting electroactive mannosyl ferrocene with a
thiol anchor was coated onto an AuNP for the multivalent display
of mannose (81). The glyco-AuNPs showed much better electro-
chemical sensitivity than a single mannosyl ferrocene counterpart,
suggesting the importance of AuNPs for signal ampliﬁcation.261 This
Fig. 17. Electrochemically-active carbohydrate derivatives prepared by the CuAAC click chemistry.
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study suggests that the construction of hybrid material-based elec-
trode architectures might further improve the sensitivity of the
carbohydrate biosensors developed to date.
4. Summary and perspective
In this review, we have highlighted recent progress in the use
of the CuAAC click chemistry for the effective construction of a variety
of functional carbohydrate structures toward the development of
new therapeutic and diagnostic tools. The 1,4-disubstituted 1,2,3-
triazole formed by CuAAC acts as both a robust linker between a
carbohydrate and a functional molecule and, in some cases, a
pharmacophore itself to enhance bioactivity. The “clicked” triazolyl
carbohydrates show a diverse range of bioactivities, including anti-
cancer, anti-microbial, anti-viral and immunostimulating effects, and
the inhibition of disease-related glycosyltransferases and glycosi-
dases. In addition, click chemistry has proven to be eﬃcient approach
for the multivalent display of carbohydrates (glycoligands) on a
variety of molecular scaffolds for high avidity lectin association.
CuAAC has also served as a versatile tool for the modiﬁcation
of carbohydrates with ﬂuorescently- or electrochemically-active
labels, producing triazolyl glycoprobes for the detection of lectins,
ions (where the triazole serves as a metal ion chelator) and small
molecules, as well as for investigating the glycobiology of live cancer
cells and pathogens. Interestingly, the clicked glycoprobes could be
used to self-assemble with different material substrates, such as
graphene and gold nanoparticles, to construct composite sensing
materials for serum diagnosis262 and drug delivery.263 In addition
to these diverse applications, CuAAC click chemistry is also ame-
nable to live cell imaging, a dynamic area which has been extensively
reviewed previously.264–269 Noteworthy within this particular
ﬁeld is recent progress in the use of bio-orthogonal CuAAC for the
species-speciﬁc ﬂuorogenic labeling of the lipopolysaccharide of
bacteria.270,271
Despite the promise of carbohydrate click chemistry, several con-
cerns need to be addressed in future investigations. First, themajority
of the clicked bioactive carbohydrate derivatives developed to date
lack a systematic evaluation of their pharmacology and pharma-
cokinetics. This is of particular importance for potential drug lead
compounds. Comparative tests are needed with both glycosylated
and carbohydrate-free molecules to elucidate the role the carbo-
hydrate plays in improving the activity, whether directly as
“warhead” or indirectly as an aid to solubility, distribution or cel-
lular uptake. A recent study also shows that the presence of triazole
may alter the physicochemical properties of bioactive glycolipids,
thereby increasing their antimicrobial activities.81 The latter point
also suggests a unique role for triazoles in the bioactivity of car-
bohydrate click adducts.
On a second front, the use of glycomimetics with improved
binding aﬃnity and/or increased multi-valency for a lectin recep-
tor could be a good tactic for the design of glycoprobes for use in
cell biology or diagnostics. CuAAC click chemistry proves to be well-
suited for this type of application due to its modularity, opening
up opportunities for the construction of compound libraries by par-
allel synthesis. Since cell surface lectins frequently recognize more
than one carbohydrate ligand, the use of glycomimetics with an en-
hanced speciﬁcity for a given target receptor might increase the
accuracy of both cellular/tissue imaging and drug delivery. Last but
not the least, going forward standardization should be a focus of
glycoprobe-incorporated sensing materials, since the size and struc-
ture of graphene and gold nanoparticles must be uniform from batch
to batch to ensure the reproducibility of the glyco-composite ma-
terials. In addition, more sophisticated tests with clinical samples
(such as whole blood, serum and tissue) should be carried out to
examine the potential of these diagnostic tools in real life diagnos-
tic applications.
In summary, “click glycosylation” has the potential to become
a general strategy for drug development and sensors design, al-
lowing the generation development and deployment of “sweet”
clinical tools in many areas of therapy and diagnosis.
5. Additional note
For a recent broader overview of CuAAC click reactions in car-
bohydrate chemistry, see Tiwari et al.272
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